
Norman Broadbent plc, along with its associated companies, furnishes expert professional services both within the United Kingdom and across international borders. The firm's extensive array of offerings includes strategic board-level guidance, temporary executive placements, specialized leadership and executive recruitment at various organizational tiers (including mezzanine roles), and comprehensive research and insight capabilities. Additionally, they provide a suite of talent development solutions such as assessment, coaching, and broader talent management initiatives. The organization, founded in 1936, maintains its principal office in London, UK.
Norman Broadbent plc trades as NBB.L on LSE. The company is classified in Industrials / Staffing & Employment Services and reports in GBP.
The current profile places the business in Staffing & Employment Services. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.
Latest available fiscal data shows £15.14M of revenue and £620,000 of net income.
Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.
The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.
Norman Broadbent plc can be compared against peers such as GenIP plc, Hydrogen Utopia International PLC, LPA Group Plc, Mercantile Ports & Logistics Limited, MYCELX Technologies Corporation, Petards Group plc.
A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.
Current signals to investigate include market capitalization of £3.60M, beta of -0.02, and return on equity of +29.2%.
This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.
Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.
NBB.L currently shows total debt of £178,000 and beta of -0.02. Missing data should be treated as a research gap, not as low risk.
Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.
No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.
Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.
No recent SEC-style filings are available for this symbol yet.
Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.
Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.
Company website: https://www.normanbroadbent.com
For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.